temozolomide has been researched along with Diarrheogenic Islet Cell Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marques, B | 1 |
| Monteiro, AR | 1 |
| Martins, RG | 1 |
| Couto, J | 1 |
| Rodrigues, F | 1 |
| Ribeiro, J | 1 |
1 other study available for temozolomide and Diarrheogenic Islet Cell Tumor
| Article | Year |
|---|---|
Metastatic VIPoma, Cosecreting Insulin, With Complete Response to Lanreotide, Capecitabine, and Temozolomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Female; Humans; Insulin; Middle Aged; | 2020 |